BRUSSELS (Reuters) - The European Medicines Agency has been in contact this month with 38 makers of potential COVID-19 vaccines, an official at the EU drugs regulator said on Tuesday.
"As of early September the EMA has been in contact with developers of 38 potential COVID-19 vaccines," Fergus Sweeney, head of clinical studies and manufacturing task force at EMA, told a hearing in the European Parliament.
Vaccines must be authorised by EMA before they can be used in the European Union. No COVID-19 vaccine has been authorised in Europe.
The World Health Organisation lists 38 candidate vaccines in clinical evaluation, including shots developed in China and Russia. Another 149 candidates are in pre-clinical evaluation.
Sweeney said EU procedures to authorise COVID-19 vaccines will follow established standards. He added that the EU was conducting enhanced monitoring on the safety of potential vaccines under development.
(Reporting by Francesco Guarascio; editing by Gareth Jones and Jason Neely)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
RECOMMENDED FOR YOU